Journals / Haydarpaşa Numune Medical Journal / 2020 / Cilt: 60 - Sayı: 4

Predictive Role of Mac-2 Binding Protein in Gastric Cancer Prognosis

Pages
395–399
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Discussion and Conclusion: The findings obtained in this study suggest that serum Mac-2BP levels may have a predictive role in both gastric tumor diagnosis and prognosis.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Introduction: Gastric cancer is one of the most common and deadly cancers worldwide.
📊
Key Findings & Data:Mac-2 binding protein (Mac-2BP) is expressed in many types of tissues, and recent studies have demon- strated that it is upregulated in various cancerous tissues.
💡
Conclusion & Impact:Discussion and Conclusion: The findings obtained in this study suggest that serum Mac-2BP levels may have a predictive role in both gastric tumor diagnosis and prognosis.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Introduction: Gastric cancer is one of the most common and deadly cancers worldwide. Currently, it is becoming an over- prevalent malignancy in Turkey. Early diagnosis and treatment have a pivotal role in ameliorating the prognosis in patients with gastric cancer. Mac-2 binding protein (Mac-2BP) is expressed in many types of tissues, and recent studies have demon- strated that it is upregulated in various cancerous tissues. We investigated the expression of Mac-2BP in patients with gastric cancer, as well as its association with clinical and pathological variables. Methods: In this study, 130 patients, 90 patients with gastric cancer and 40 healthy controls were included. Serum Mac-2BP levels were measured in both groups. Clinical and pathological variables, including tumor size, histologic grade, primary tu- mor stage, lymph node metastasis, lymphatic invasion, vascular invasion, and neural invasion, were evaluated in the gastric cancer group. Results: Circulating Mac-2BP levels were higher in patients with gastric cancer than the control group. Serum Mac-2BP levels especially elevated in patients with larger tumor size, poor histologic grade, advanced primary tumor stage, lymph node metastasis, lymphatic invasion, vascular invasion, and neural invasion. Discussion and Conclusion: The findings obtained in this study suggest that serum Mac-2BP levels may have a predictive role in both gastric tumor diagnosis and prognosis.

🔖

Cite This Article

KARAYAĞIZ, H., KATMER, T., SEKMEN, Ü., ÇELEBİ, M. M., PAKSOY, M. (2020). Predictive Role of Mac-2 Binding Protein in Gastric Cancer Prognosis. Haydarpaşa Numune Medical Journal, Cilt: 60 - Sayı: 4, 395–399. https://ajindex.com/articles/165927

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011;61:69–90
  2. Wu K, Nie Y, Guo C, Chen Y, Ding J, Fan D. Molecular basis of therapeutic approaches to gastric cancer. J Gastroenterol Hepatol 2009;24:37–41
  3. Gurzu S, Orlowska J, Sugimura H, Bara T, Szentirmay Z, Januszewicz W, et al. Immunohistochemical features and staging of early gastric cancer. Arch Med Sci 2017;13:1373–82
  4. Ren J, Chen Z, Juan SJ, Yong XY, Pan BR, Fan DM. Detection of circulating gastric carcinoma-associated antigen MG7-Ag in human sera using an established single determinant immuno- polymerase chain reaction technique. Cancer 2000;88:280–5
  5. Xu Y, Zhang L, Hu G. Potential application of alternatively gly- cosylated serum MUC1 and MUC5AC in gastric cancer diagno- sis. Biologicals 2009;37:18–25
  6. Kon OL, Yip TT, Ho MF, Chan WH, Wong WK, Tan SY, et al. The distinctive gastric fluid proteome in gastric cancer reveals a multi-biomarker diagnostic profile. BMC Med Genomics 2008;1:54
  7. Adachi J, Kumar C, Zhang Y, Olsen JV, Mann M. The human urinary proteome contains more than 1500 proteins, includ- ing a large proportion of membrane proteins. Genome Biol 2006;7:R80
  8. Yamaguchi T, Takahashi T, Yokota T, Kitamura K, Noguchi A, Kamiguchi M, et al. Urinary pepsinogen I as a tumor marker of stomach cancer after total gastrectomy. Cancer 1991;68:906–9
  9. Dong LM, Shu XO, Gao YT, Milne G, Ji BT, Yang G, et al. Urinary prostaglandin E2 metabolite and gastric cancer risk in the Shanghai women's health study. Cancer Epidemiol Biomark- ers Prev 2009;18:3075–8
  10. Tsigris C, Karayiannakis AJ, Syrigos KN, Zbar A, Diamantis T, Kalahanis N, et al. Clinical significance of soluble c-erbB-2 levels in the serum and urine of patients with gastric cancer. Anticancer Res 2002;22:3061–5
  11. Iacobelli S, Arnò E, D'Orazio A, Coletti G. Detection of anti- gens recognized by a novel monoclonal antibody in tissue and serum from patients with breast cancer. Cancer Res 1986;46:3005–10
  12. Iacobelli S, Bucci I, D'Egidio M, Giuliani C, Natoli C, Tinari N, et al. Purification and characterization of a 90 kDa protein released from human tumors and tumor cell lines. FEBS Lett 1993;319:59–65
  13. Ullrich A, Sures I, D'Egidio M, Jallal B, Powell TJ, Herbst R, et al. The secreted tumor-associated antigen 90K is a potent im- mune stimulator. J Biol Chem 1994;269:18401–7
  14. Natoli C, Iacobelli S, Kohn L. The immune stimulatory protein 90K increases major h